Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Neuren Pharmaceuticals Limited invites its shareholders to attend the hybrid Annual Shareholders’ Meeting on May 28, 2024, offering both in-person attendance in Melbourne and live online participation with voting and Q&A capabilities. Shareholders are encouraged to vote via proxy in advance and stay updated on potential changes via the company’s website and ASX announcements. The company also urges shareholders to opt for receiving communications electronically for efficiency.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.
